Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice den Hertog

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Mycobacteriology|January 4, 2017
New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimensRichard M Anthony, Alice den Hertog, Mikael Mansjö, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 6, 2010
Misleading conclusionPaul Klatser, Richard Anthony, Alice den Hertog, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 8, 2016
Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosisMarlanka A Zuur, Mathieu S Bolhuis, Richard Anthony, et al.
Scientific Reports|November 1, 2017
IP-10 Kinetics in the First Week of Therapy are Strongly Associated with Bacteriological Confirmation of Tuberculosis Diagnosis in HIV-Infected PatientsAlberto L García-Basteiro, Edson Mambuque, Alice den Hertog, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Mycobacteriology|January 4, 2017
New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimensRichard M Anthony, Alice den Hertog, Mikael Mansjö, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 6, 2010
Misleading conclusionPaul Klatser, Richard Anthony, Alice den Hertog, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 8, 2016
Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosisMarlanka A Zuur, Mathieu S Bolhuis, Richard Anthony, et al.
Scientific Reports|November 1, 2017
IP-10 Kinetics in the First Week of Therapy are Strongly Associated with Bacteriological Confirmation of Tuberculosis Diagnosis in HIV-Infected PatientsAlberto L García-Basteiro, Edson Mambuque, Alice den Hertog, et al.
Pageof 1